Vasil'ev V N
Vopr Med Khim. 1980 Nov-Dec;26(6):782-6.
A 30-fold increase in excretion of L-DOPA, distinct elevation in synthesis of dopamine and noradrenaline as well as inhibition of adrenaline synthesis occurred in schizophrenic patients at an acute period after administration of 0.1 g of L-DOPA per os (L-DOPA test). As shown by the L-DOPA test, excretion of L-DOPA was distinctly decreased in the patients with the remittence step as compared with the acute period. At the same time, in the remission synthesis of dopamine occurred mainly in the night time, synthesis of noradrenaline was decreased as compared with the acute period. synthesis of dopamine was increased 8-fold both in the patients at the acute period (mainly in the day-time) and within the remittence period (in the night-time) of the disease. The variations in excretion of L-DOPA, dopamine and noradrenaline, found in schizophrenic patients, were markedly distinct from dynamics of these patterns in healthy adult persons but were more similar to the parameters characteristic for persons in old and senile age. The L-DOPA test developed might be used for diagnosis of schizophrenia and of its periods (acute period and remission).
在精神分裂症患者口服0.1 g左旋多巴后急性期(左旋多巴试验),左旋多巴排泄量增加30倍,多巴胺和去甲肾上腺素合成明显升高,同时肾上腺素合成受到抑制。如左旋多巴试验所示,与急性期相比,处于缓解期的患者左旋多巴排泄量明显降低。与此同时,在缓解期多巴胺合成主要发生在夜间,去甲肾上腺素合成与急性期相比减少。在疾病的急性期(主要在白天)和缓解期(在夜间),患者的多巴胺合成均增加了8倍。精神分裂症患者中左旋多巴、多巴胺和去甲肾上腺素排泄的变化与健康成年人这些模式的动态变化明显不同,但更类似于老年人和高龄者的特征参数。所开发的左旋多巴试验可用于精神分裂症及其分期(急性期和缓解期)的诊断。